Dr. Chavin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Water St
Cambridge, MA 02141
Summary
- Dr. Jeffrey Chavin is a neurologist in Cambridge, MA. He received his medical degree from Temple University School of Medicine and has been in practice 27 years. He specializes in neuroimmunology/multiple sclerosis and neuromuscular medicine and is experienced in neuromuscular medicine, neuroimmunology (multiple sclerosis), and muscular dystrophy.
Education & Training
- Tufts Medical CenterResidency, Neurology, 1995 - 1996
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Neurology, 1992 - 1995
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1991 - 1992
- Lewis Katz School of Medicine at Temple UniversityClass of 1990
Certifications & Licensure
- MA State Medical License 1995 - 2026
- PA State Medical License 1993 - 1995
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 18 citationsBiochemical and genetic studies in a family with mitochondrial myopathyTerry Heiman-Patterson, Zohar Argov, Jeffrey M. Chavin, Bernadette Kalman, Hansjuerg Alder
Muscle & Nerve. 1997-10-01 - 15 citationsComparative effectiveness of teriflunomide and dimethyl fumarate in patients with relapsing forms of MS in the retrospective real-world Teri-RADAR study.Robert Zivadinov, Kiren Kresa-Reahl, Bianca Weinstock-Guttman, Keith R. Edwards, Chakkarin Burudpakdee
Journal of Comparative Effectiveness Research. 2019-02-13 - 2 citationsPrior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosisGiancarlo Comi, Mark S. Freedman, José Meca-Lallana, Patrick Vermersch, Byoung Joon Kim
BMC Neurology. 2020-10-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: